To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Thromboprophylaxis with rivaroxaban versus enoxaparin in total knee and hip arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2016

Thromboprophylaxis with rivaroxaban versus enoxaparin in total knee and hip arthroplasty

Vol: 5| Issue: 6| Number:12| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials

Sci Rep. 2016 Mar 29;6:23726

Contributing Authors:
GZ Ning SL Kan LX Chen L Shangguan SQ Feng Y Zhou

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Nine randomized controlled trials which compared rivaroxaban to enoxaparin for thromboprophylaxis in total knee and total hip arthroplasty were selected for inclusion. Meta-analysis was performed for incidences of symptomatic venous thromboembolism (VTE), major bleeding, clinically-relevant non-major bleeding, all-cause mortality, and postoperative wound infection. Trial sequential analysis was al...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue